132 related articles for article (PubMed ID: 7915264)
1. Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the glioma cells.
Takaoka T; Yoshida J; Mizuno M; Sugita K
Jpn J Cancer Res; 1994 Jul; 85(7):750-5. PubMed ID: 7915264
[TBL] [Abstract][Full Text] [Related]
2. Cytolysis of malignant glioma cells by lymphokine-activated killer cells combined with anti-CD3/antiglioma bifunctional antibody and tumor necrosis factor-alpha.
Yoshida J; Takaoka T; Mizuno M; Momota H; Okada H
J Surg Oncol; 1996 Jul; 62(3):177-82. PubMed ID: 8667624
[TBL] [Abstract][Full Text] [Related]
3. Liposomal transfection of human gamma-interferon gene into human glioma cells and adoptive immunotherapy using lymphokine-activated killer cells.
Mizuno M; Yoshida J; Takaoka T; Sugita K
J Neurosurg; 1994 Mar; 80(3):510-4. PubMed ID: 7906727
[TBL] [Abstract][Full Text] [Related]
4. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
[TBL] [Abstract][Full Text] [Related]
5. Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection with the tumor necrosis factor-alpha gene.
Tashiro T; Yoshida J; Mizuno M; Sugita K
J Neurosurg; 1993 Feb; 78(2):252-6. PubMed ID: 8421207
[TBL] [Abstract][Full Text] [Related]
6. Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection of the killer cells with the gamma-interferon gene.
Mizuno M; Yoshida J; Takaoka T; Sugita K
Jpn J Cancer Res; 1995 Jan; 86(1):95-100. PubMed ID: 7537727
[TBL] [Abstract][Full Text] [Related]
7. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.
Campbell SC; Tanabe K; Alexander JP; Edinger M; Tubbs RR; Klein EA
J Urol; 1994 May; 151(5):1385-90. PubMed ID: 7908992
[TBL] [Abstract][Full Text] [Related]
8. [Enhanced anti-tumor effect of lymphokine-activated killer cells transfected with tumor necrosis factor-alpha gene on human glioma cells].
Tashiro T
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):742-9. PubMed ID: 7959591
[TBL] [Abstract][Full Text] [Related]
9. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.
Fady C; Gardner A; Gera JF; Lichtenstein A
Cancer Immunol Immunother; 1993 Oct; 37(5):329-36. PubMed ID: 8104695
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
[TBL] [Abstract][Full Text] [Related]
12. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD
Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063
[TBL] [Abstract][Full Text] [Related]
13. Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.
Jansen JH; van der Harst D; Wientjens GJ; Kooy-Winkelaar YM; Brand A; Willemze R; Kluin-Nelemans HC
Blood; 1992 Jul; 80(2):478-83. PubMed ID: 1352710
[TBL] [Abstract][Full Text] [Related]
14. Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing.
Katsanis E; Bausero MA; Xu H; Orchard PJ; Xu Z; McIvor RS; Brian AA; Blazar BR
Cancer Immunol Immunother; 1994 Feb; 38(2):135-41. PubMed ID: 7905790
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
Tomita Y; Watanabe H; Kobayashi H; Nishiyama T; Tsuji S; Fujiwara M; Sato S
Cancer Immunol Immunother; 1992; 35(6):381-7. PubMed ID: 1356627
[TBL] [Abstract][Full Text] [Related]
16. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
[TBL] [Abstract][Full Text] [Related]
17. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
18. Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor.
Matory YL; Dorfman DM; Wu L; Chen M; Goedegebuure P; Eberlein TJ
Pathobiology; 1999; 67(4):186-95. PubMed ID: 10738180
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.
Budinsky AC; Brodowicz T; Wiltschke C; Czerwenka K; Michl I; Krainer M; Zielinski CC
Int J Cancer; 1997 Jun; 71(6):1086-90. PubMed ID: 9185715
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
Schellhorn M; Haustein M; Frank M; Linnebacher M; Hinz B
Oncotarget; 2015 Nov; 6(36):39342-56. PubMed ID: 26513172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
